Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HLA-A2 restricted synthetic peptide vaccine |
Synonyms | |
Therapy Description |
HLA-A2 restricted synthetic peptide vaccine is a cancer vaccine comprised of synthetic peptides for tumor associated antigens, which may induce increased anti-tumor immune response (PMID: 23955319). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HLA-A2 restricted synthetic peptide vaccine | HLA-A2 restricted synthetic tumor antigen | HLA-A2 restricted synthetic peptide vaccine is a cancer vaccine comprised of synthetic peptides for tumor associated antigens, which may induce increased anti-tumor immune response (PMID: 23955319). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|